Journal of Psychedelic Studies
June 19, 2023
Tra-Ill Dowie, Julien Tempone-Wiltshire
24 citations
Abstract The intersection between philosophy and psychedelics is explored in the book “Philosophy and Psychedelics: Frameworks for Exceptional Experience”. The authors aim to develop a dialogue between the two disciplines and explore the various frameworks for understanding exceptional experiences that psychedelics have afforded human beings. The book delves into foundational, ontological, and...
Journal of Psychedelic Studies
June 19, 2023
Kevin Byrne, Spencer Lindsay, Nicholas Baker et al.
4 citations
Abstract Background and aims Most modern modalities of psychedelic-assisted psychotherapy (PAP) aim to minimize harm and maximize support by utilizing close, formalized supervision for a single participant per session. However, these substances are used naturalistically in a wide variety of settings. Our goal was to evaluate the perceived benefits and harms of naturalistic psychedelic use in...
Journal of Psychedelic Studies
June 9, 2023
Beatriz Caiuby Labate, Anna O. Ermakova, Jordan Sloshower et al.
1 citation
Abstract On February 2023, the Drug Enforcement Administration (DEA) released a document to the legal team representing the Church of the Eagle and the Condor (“CEC”). This disclosure came two years after the church, in conjunction with Chacruna Institute, submitted two FOIA requests to the DEA and the Department of Justice requesting all records pertaining to ayahuasca. This report, titled...
Journal of Psychedelic Studies
May 16, 2023
Benjamin A. Korman
7 citations
Abstract Background Despite recent research linking lifetime classic psychedelic use to positive mental health outcomes, little work has explored the role played by classic psychedelics in healthy users' ability to cope with ordinary, yet stressful, life situations. Aims This study begins to fill this gap by exploring whether lifetime classic psychedelic use is associated with attenuated or...
Journal of Psychedelic Studies
April 27, 2023
Mateo Sánchez Petrement
10 citations
AbstractCoinciding with and responding to a growing crisis in the diagnostic, explanatory and treatment systems of psychiatry, the last couple of decades have seen a growing amount of evidence regarding the therapeutic potential of psychedelic drugs to treat a variety of mental health conditions. Broadly, this crisis can be construed as that of “indivi/dualist” approaches which aim to treat...
Journal of Psychedelic Studies
April 27, 2023
Kevin O. St. Arnaud, Donald Sharpe
6 citations
AbstractBackground and aimsAlthough numerous cultures have used psychoactive substances for spiritual, or entheogenic, purposes, little is known about contemporary entheogenic spirituality, particularly outside of the few traditions that retain sacramental drug use practices.MethodTo better conceptualize contemporary patterns of entheogenic drug use, an international, online study of...
Journal of Psychedelic Studies
April 27, 2023
Riley D. Kirk, Olivia M. Uhley, Paloma Lehfeldt et al.
AbstractBackgroundEntheogen use is becoming increasingly popular and a potential option for treatment or adjuvant treatment for various medical conditions. Clinical studies are needed to determine the efficacy, safety, and possible role of these traditional medicines in the context of modern society and the Western medicine paradigm. The willingness of patients to participate in such studies is...
Journal of Psychedelic Studies
March 28, 2023
Colin H. Simonds
6 citations
Abstract Whether occasioned through careful, consistent meditative practice or through quicker means like the ritual ingestion of psilocybin or ayahuasca, global contemplative practices have established effective systems of implementing, directing, and integrating the very kinds of non-ordinary experiences central to psychedelic use. However, contemplative traditions are largely absent from the...
Journal of Psychedelic Studies
March 3, 2023
Samuli Kangaslampi
Ingestion or administration of classic psychedelics is sometimes associated with improvements in well-being or mental health. Acute mystical-type experiences that psychedelics occasion have been suggested to be related to such improvements. Meanwhile, other features of the psychedelic experience, such as psychological insights and emotional breakthroughs, are also increasingly being studied....
Journal of Psychedelic Studies
January 18, 2023
Benjamin R. Lewis, Kevin Byrne, John Hendrick et al.
22 citations
Abstract Background Psilocybin-assisted psychotherapy has demonstrated significant promise as a treatment for depression, anxiety, and existential distress associated with serious medical illness and has generally been employed on an individual basis, which presents challenges for scaling and resource availability. There are also compelling theoretical reasons to suggest that group-based...
Journal of Psychedelic Studies
January 17, 2023
Ioana Pop, Jannis Dinkelacker
4 citations
Abstract Background and aims Previous research has proposed that microdosing, i.e., the repeated use of sub-threshold doses of serotonergic hallucinogens, has an impact on mood by increasing emotional awareness. We propose that increased emotional awareness could translate into higher emodiversity, a balanced experience of emotions in which emotions are experienced with more similarity in...
Journal of Psychedelic Studies
January 16, 2023
Anna Lutkajtis, Jules Evans
58 citations
Abstract This article reports on integration challenges that were experienced by nine individuals who attended a three-day legal psilocybin truffle retreat in the Netherlands. The study employed a qualitative phenomenological approach, using semi-structured interviews to gain an understanding of participants' ( n = 30) psilocybin experiences and their after-effects. While the study did not...
Journal of Psychedelic Studies
January 16, 2023
Benjamin A. Korman
7 citations
Abstract Background and aims Although large-scale population studies have linked the use of classic psychedelics (lysergic acid diethylamide, psilocybin, or mescaline) to reduced odds of physical health problems, mental health problems, and criminal behavior, the roughly 35 million adults in the United States who have used classic psychedelics are nonetheless stigmatized in the American job...
Journal of Psychedelic Studies
January 16, 2023
Madeline Brendle, Anya Ragnhildstveit, Matthew Slayton et al.
7 citations
Ketamine and esketamine have garnered interest in both psychiatric research and clinical practice for treatment-resistant depression (TRD). In this review, we examined registered trials investigating the therapeutic use of ketamine or esketamine for TRD, with the aim of characterizing emerging trends and knowledge gaps.The ClinicalTrials.gov electronic registry and results database was queried...
Journal of Psychedelic Studies
January 16, 2023
Stephen Kagan
5 citations
AbstractAimThis study examines narratives describing complex psychedelic experiences after smoking N,N-dimethyltryptamine.MethodsThe narrative accounts examined here were gathered from a variety of online sites and analyzed in order to discover themes, categories and patterns in the phenomenon of the resulting psychedelic experiences.ResultsSubjects reported seeing complex and unusual visual...
Journal of Psychedelic Studies
January 16, 2023
Mitch Earleywine, Philip Kamilar-Britt
AbstractPsychedelic compounds hold promise for alleviating human suffering. Initial trials of psychedelic-assisted treatments have established feasibility and safety, generating calls for replications. Meanwhile, social and medical sciences have drawn criticism due to perceptions of replication failures and varying public trust in empiricism. Data suggest that researchers and the public...
Journal of Psychedelic Studies
December 8, 2022
A. Atoian, Harry C. R. Bowles, Sarah Gerhke et al.
The COVID-19 pandemic exacerbated pre-existing high-levels of physician stress and burnout1. In order to help treat frontline colleagues who were diagnosed with acute stress disorder, we chose a non-psychedelic, ketamine micro-dose treatment strategy for symptom management.We provided care virtually, and all patients were prescribed sublingual ketamine once daily. Each patient was evaluated...
Journal of Psychedelic Studies
December 7, 2022
Geoffrey M. Bove, David J. Mokler
8 citations
Abstract Background and Aims The hallucinogenic drug psilocybin is being widely tested in humans for the treatment of psychiatric disorders. Psilocybin and other psychedelics are proposed to work through serotonin 2a (5-HT2a) receptors, which are tightly linked to immune function. The purpose of the present study was to assess the effects of a single dose of psilocybin on a panel of cytokines,...
Journal of Psychedelic Studies
October 24, 2022
Elizabeth Wolfson
12 citations
Abstract A renaissance is underway as research studies are substantiating psychotherapeutic and physiological benefits of psychedelic medicines, along with advancements towards legalization, expansion of professional training programs and a renewed cultural recognition of the healing qualities of the medicines. Pending legislation, a cadre of trained psychotherapists are poised to apply their...
Journal of Psychedelic Studies
September 21, 2022
Thais Guimarães Bourscheid, Leonardo Corrêa Cardoso, Marcelo Henrique Nascimento Santana et al.
3 citations
Abstract Snuff is a fine aromatic powder composed of dried and thin leaves combined with tobacco, roots, peels, and seeds. Its use for indigenous religious purposes has appeared since pre-Columbian period in various localities of American continent. Practice is considered sacred in indigenous culture and suffered from trivialization of consumption due to influence of colonizers, which triggered...
Journal of Psychedelic Studies
September 16, 2022
Ada Kałużna, Marco Schlosser, Emily Gulliksen Craste et al.
41 citations
Abstract Background and aims Despite promising findings indicating the therapeutic potential of psychedelic experience across a variety of domains, the mechanisms and factors affecting its efficacy remain unclear. The present paper explores this by focusing on two psychedelic states which have been suggested as therapeutically significant in past literature: ego-dissolution and connectedness....
Journal of Psychedelic Studies
September 16, 2022
Chelsea Radakovic, Ratko Radaković, Guy Peryer et al.
23 citations
Abstract Background and aims The benefits of classic serotonergic psychedelics (e.g. psilocybin, LSD, DMT, ayahuasca) are becoming more widely known with the resurgence in research in the past decade. Furthermore, the benefits of mindfulness are well documented. However, no systematic reviews have examined linkage of mindfulness and psychedelics use. The aim of this systematic review is to...
Journal of Psychedelic Studies
September 2, 2022
Ismael Apud, Juan Scuro, Ignacio Carrera et al.
6 citations
Abstract Background Ayahuasca's psychological and subjective effects were compared in rituals of two neoshamanic groups in Uruguay. Aims Compare, describe and analyze psychological effects and subjective experiences of ayahuasca ceremonies in two different groups: a psychospiritual holistic center, and a center specialized in substance use disorder's treatment. Methods A mixed...
Journal of Psychedelic Studies
August 18, 2022
Corey Botansky, John Innes
2 citations
Abstract Empirical research supports the use of psychoactive drugs to augment psychotherapy for the treatment of mental illness. The use of such drugs, however, is still resisted by many in the medical community and this transfers to resistance in the wider community. The stigma of controversy surrounding the drugs, further enhanced by the stigma of mental illness, hinders community acceptance....
Journal of Psychedelic Studies
August 8, 2022
Alexander Irvine, David Luke
27 citations
Abstract Background and Aims Little is known about individual differences in Hallucinogen Persisting Perceptual Disorder (HPPD). This study investigated visual processing style and personality across two HPPD types (HPPD I and HPPD II) and a Non-HPPD group. Methods An online survey was delivered to participants sourced from online HPPD and psychedelic user groups and forums ( N = 117). Using...